Is SRG's EPS trend in 2024 a concern for investors?
4/7/2025 04:14pm
**Seritage Growth Properties (SRG) experienced a significant decline in EPS in 2024, which is a concern for investors.**
1. **Significant EPS Decline**: The EPS for SRG in 2024 was -$2.82, which is a substantial negative figure compared to any positive figure in previous years. This indicates a severe downturn in the company's profitability.
|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|SRG|SRG.N|Seritage Growth|2024 Q1|68.14159292035397|-0.36|169|
|SRG|SRG.N|Seritage Growth|2024 Q2|-5.202312138728328|-1.82|169|
|SRG|SRG.N|Seritage Growth|2024 Q3|-925|-0.41|169|
2. **Negative Investor Sentiment**: The company's stock price decreased by 5.88% following the release of financial results, reflecting investor disappointment. Additionally, SRG's stock was upgraded to a "sell" rating by StockNews.com, which further suggests that investors are concerned about the company's prospects.
3. **Operational Challenges**: SRG faced significant challenges, including market difficulties and the need to sell assets to raise funds. These operational hurdles likely contributed to the negative EPS.
4. **Financial Health Concerns**: The company's financial health is under pressure, with a net loss of $20.2 million for the first quarter of 2024, or ($0.36) per share. This loss, coupled with a negative EPS, raises questions about the company's ability to sustain itself financially.
5. **Strategic Asset Sales**: Despite these challenges, SRG has been actively selling assets to generate cash. For example, they sold $48.8 million worth of assets in the first quarter of 2024. These sales may help mitigate some of the financial pressures, but the negative EPS indicates that more needs to be done to restore profitability.
In conclusion, the negative EPS trend for SRG in 2024 is a major red flag for investors, signaling significant financial distress and the need for the company to implement effective strategies to improve its financial health and profitability.